Dr Rachel Cafferty, MD | |
13123 E 16th Ave, Aurora, CO 80045-7106 | |
(720) 777-1234 | |
Not Available |
Full Name | Dr Rachel Cafferty |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 13123 E 16th Ave, Aurora, Colorado |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194137471 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080P0204X | Pediatrics - Pediatric Emergency Medicine | DR.0060245 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Rachel Cafferty, MD Po Box 110429, Aurora, CO 80042-0429 Ph: () - | Dr Rachel Cafferty, MD 13123 E 16th Ave, Aurora, CO 80045-7106 Ph: (720) 777-1234 |
News Archive
New insights into how human cytomegalovirus, the leading cause of birth defects associated with infection spreads from pregnant mother to fetus and from organ to organ in newborns provides translational researchers an exciting new avenue for investigation that may lead to the development of therapeutic interventions.
A study of an unusual snapping turtle with one lung found shared characteristics with humans born with one lung who survive beyond infancy. Digital 3D anatomical models created by Emma Schachner, PhD, Assistant Professor of Cell Biology & Anatomy at LSU Health New Orleans School of Medicine, made the detailed research possible.
Working at a Saint Louis University laboratory, second-year medical student Weston Gordon performed several studies investigating two novel drug therapies that may be useful in the treatment of peripheral vascular disease in patients with Type 2 diabetes.
Genzyme, a Sanofi company, today announced positive new data from the Phase 3 ENGAGE and ENCORE studies of eliglustat tartrate, its investigational oral therapy for Gaucher disease type 1.
Researchers at the Moffitt Cancer Center have found that delayed tumor growth and enhanced survival of mice bearing melanoma were possible by blocking the reconstitution of myeloid-derived suppressor cells and Tregs (suppressors of anti-tumor activity) after total body irradiation had eliminated them. Blocking myeloid-derived suppressor cells and regulatory T-cell reconstitution improved adoptive T-cell therapy, an immunotherapy designed to suppress tumor activity.
› Verified 8 days ago
Dr. Jonathan Orsborn, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Dr. Joel A. Friedlander, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 Fax: 720-777-7277 | |
Dr. Emily Greenwald, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Children's Hospital Colorado, Aurora, CO 80045 Phone: 720-777-1234 | |
Jessica Boat Landry, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Robert Kramer, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Richard W. Penland, Pediatrics Medicare: Medicare Enrolled Practice Location: 1501 S Potomac St, Aurora, CO 80012 Phone: 303-695-2628 Fax: 303-306-7753 | |
John Roger Hollister, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 |